PipelineReview.com - Biotech News & Online Store

Press Room

Date	Item Title
28 Mar 2008	Cancer and TNF antibodies boost Biologics Sales in 2007
11 Feb 2008	2008 is a decisive year for the validation of the asthma target interleukin-13
23 Jul 2007	114 Blockbuster Drugs Accounted for 2006 Sales of US$ 233.7 bln
30 May 2007	The imminent change of the antithrombotics market
02 May 2007	Up and down with cholesterol management
25 Apr 2007	Beyond biogenerics: the real threats for therapeutic proteins
15 Mar 2007	La Merie and PharmaPlus team up to provide No-Frills business intelligence solutions
08 Mar 2007	Weight management is not enough for cannabinoid type 1 (CB1) receptor antagonists to become a commercial success
01 Mar 2007	The new class of dipeptidyl peptidase IV (DPP-IV) inhibitors has one clear leader and many followers
26 Feb 2007	TOP Classes of Biologics with 2006 Sales of US$ 63.8 bln
14 Feb 2007	The market of recombinant coagulation factors is growing with next generation products
05 Feb 2007	Dosing convenience is mandatory to keep pace in the pipeline race of GLP-1 analogs for type 2 diabetes
02 Feb 2007	Overview On 2006 Sales Of TOP 20 Biologics To Be Released On February 26
11 Jan 2007	The right balance drives the field of PPAR agonist R&D
19 Sep 2006	Delivery improvements of the AMD-drug Lucentis on the way
07 Sep 2006	Biologics define new standard of therapy in psoriasis
16 Aug 2006	The Crowded Field of VEGF and VEGF-R Targeting Drugs
01 Aug 2006	A Full Pipeline of Follow-on TNF-Antagonists
19 Jun 2006	Biogenerics and new technologies compete with 1st generation major protein products
02 Jun 2006	Imminent launches of new EPO products and consolidation of the biogenerics field
30 May 2006	Localized delivery of PDE-4 inhibitors to open the therapeutic window
18 May 2006	The next generation of interferons needs improvement in efficacy and safety
09 May 2006	RNA interference (RNAi) is coming of age as a therapeutic modality
13 Mar 2006	The irresistible sirena's chant of needle-free insulins
06 Mar 2006	Antibodies are the first wave of IGF-1R antagonists for cancer therapy
22 Feb 2006	Dawn has broken for obesity treatment with cannabinoid receptor (CB1) antagonists
14 Feb 2006	TOP 20 Biologics now with sales of US$ 37.7 bln in 2005
07 Feb 2006	Dosing convenience mandates the pipeline of glucagon-like peptide-1 (GLP-1) analogs for type 2 diabetes
31 Jan 2006	Emerging diabetes drugs in early development
24 Jan 2006	High interest in inhibitors of the novel target sodium-dependent glucose (co-) transporter (SGLT) for therapy of type 2 diabetes
18 Jan 2006	Tight race to be the first in a new class of dipeptidyl peptidase IV (DPP-IV) inhibitors for the oral treatment of type 2 diabetes
15 Nov 2005	Competition is needed in the follicle stimulating hormone (FSH) market
01 Nov 2005	Thrombolytic therapy needs innovation
26 Oct 2005	A biogeneric company leads the field of next generation human growth hormone (hGH)
18 Oct 2005	Too many companies with biogeneric G-CSF products compete for a small market
11 Oct 2005	Smaller is better for thrombopoiesis-stimulating agents
07 Oct 2005	Patent expiry of epoetin alfa in Europe attracts 10 companies with biogeneric erythropoietin

<< Start < Prev 1 Next > End >>
Results 1 - 37 of 37

Search in our News Channels

Search in our Online Store